HIGH CONTENT SCREENING MARKET ANALYSIS

Market Challenges And Opportunities

Global High Content Screening Market – Driver

R&D in drug discovery is expected to propel growth of the global high content screening (HCS) market over the forecast period. For instance, in February 2020, researchers from Purdue University,  a public land-grant research university, reported assessment of the effects of IL-27 – a heterodimeric cytokine composed of subunits IL-27p28 and EBI3 (Epstein–Barr virus-induced gene 3) – on the gene expression changes of TC2R prostate adenocarcinoma cells. HCS was used to identify RNAi (RNA interference) that cut down messenger RNAs that code those specific proteins which caused changes on the gene expression changes of TC2R prostate adenocarcinoma cells.

Moreover, increasing investment in HCS is expected to aid in growth of the market. For instance, in January 2020, St. Jude Children’s Research Hospital invested US$ 13.4 million for building a laboratory resource center, which will include two new labs, the Center for Modeling Human Pediatric Diseases and High Content Screening.

Global High Content Screening Market – Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease spread to over 100 countries across the globe, and the World Health Organization declared it a public health emergency on January 30, 2020. The coronavirus pandemic initially led to sharp decreases in the use of recommended cancer  HCS  tests, which could mean that some early cancers may have gone undetected. Before the beginning of the pandemic, according to the data published by Journal of clinical oncology 24% postponed a mammogram, 27% postponed a Pap test, 27% postponed an HPV test, 11% postponed a stool blood test, and 36% postponed a colonoscopy. Cancer screenings were delayed as a result of the pandemic,  Thus, delays for testing affected the market negatively. On the other hand, virtual screening methods at laboratories around the world after lifting of the lockdowns, led to collection of hude amounts of data about COVID-19 virus and its close relationship with other SARS viruses. Thus it could overall be called as a moderate impact.

Cell imaging and analysis equipment is the dominant product type due to increase in R&D and investment in healthcare infrastructure for exploration of chronic diseases.

Global High Content Screening Market: Restraint

Image analysis for HCS is a time-consuming and labor-intensive process, which is expected to hinder growth of the market. Moreover, lack of budget for high-end HCS instruments in emerging economies is expected to hamper growth of the market over forecast period.

Global High Content Screening Market – Driver

• Increase in R & D for drug treatment exploration.
• Investments in manufacturing of HCS systems
• Partnerships and collaborations among pharmaceutical companies

Restraints & Challenges:

• Labour intensive and time consuming process
• Lack of budget for high-end HCS instruments in emerging economies